desoxycorticosterone has been researched along with Endomyocardial Fibrosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordasic, N; Hartner, A; Hilgers, KF; Rascher, W | 1 |
| Lijnen, PJ | 1 |
| Brown, L; Fairlie, DP; Iyer, A; Reid, RC; Stylianou, C; Taylor, SM; Woodruff, TM; Wu, MC | 1 |
| Chen, HW; Feng, KF; He, LF; Hu, H; Hua, JS; Li, Q; Ma, LK; Wang, L; Yu, H; Zhou, JL | 1 |
| Bouzeghrane, F; Reinhardt, DP; Reudelhuber, TL; Thibault, G | 1 |
| Inoue, H; Ishimaru, K; Kagitani, S; Takabayashi, D; Takata, M; Ueno, H | 1 |
| Campbell, SE; Diaz-Arias, AA; Ganjam, VK; Griffing, GT; Slight, SH; Sun, Y; Swinfard, RW; Weber, KT | 1 |
| Young, M | 1 |
| Dilley, R; Fullerton, M; Funder, J; Young, M | 1 |
| Brown, L; Duce, B; Miric, G; Sernia, C | 1 |
| Brilla, CG; Weber, KT | 1 |
1 review(s) available for desoxycorticosterone and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Deletion of the alpha-8 integrin gene does not protect mice from myocardial fibrosis in DOCA hypertension.
Topics: Animals; Desoxycorticosterone; Disease Models, Animal; DNA; Endomyocardial Fibrosis; Gene Deletion; Hypertension; Integrin alpha Chains; Mice; Myocardium | 2009 |
10 other study(ies) available for desoxycorticosterone and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Deletion of the alpha8 integrin gene does not protect mice from myocardial fibrosis in DOCA hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; DNA; Endomyocardial Fibrosis; Gene Expression; Hypertension; Immunohistochemistry; Integrin alpha Chains; Mice; Mice, Inbred C57BL; Reverse Transcriptase Polymerase Chain Reaction; Sequence Deletion | 2009 |
Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Pressure; Cardiac Output; Cicatrix; Collagen; Coronary Circulation; Desoxycorticosterone; Echocardiography; Endomyocardial Fibrosis; Gene Expression; Heart; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Leukocytes, Mononuclear; Male; Mast Cells; Myocardium; Nitroprusside; Norepinephrine; Peptides, Cyclic; Rats; Rats, Wistar; Receptor, Anaphylatoxin C5a; Vasoconstriction; Vasodilation; Ventricular Dysfunction | 2011 |
Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
Topics: Animals; Benzamides; Blood Pressure; Blotting, Western; Desoxycorticosterone; Disease Models, Animal; Endomyocardial Fibrosis; Fibronectins; Fibrosis; Hypertension; Imatinib Mesylate; Male; Nephrectomy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Tenascin; Treatment Outcome | 2012 |
Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis.
Topics: Angiotensin II; Animals; Cells, Cultured; Desoxycorticosterone; Disease Models, Animal; Endomyocardial Fibrosis; Extracellular Matrix; Fibrillin-1; Fibrillins; Fibroblasts; Integrins; Male; Mice; Mice, Transgenic; Microfilament Proteins; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vasoconstrictor Agents | 2005 |
Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blood Pressure; Cytokines; Desoxycorticosterone; Endomyocardial Fibrosis; Fibrillar Collagens; Gene Expression; Hypertension; Inflammation; Macrophages; Male; Mineralocorticoids; Monocytes; Plasminogen Activator Inhibitor 1; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride, Dietary | 2007 |
Chronic mineralocorticoid excess and cardiovascular remodeling.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adult; Aldosterone; Animals; Desoxycorticosterone; Endomyocardial Fibrosis; Female; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Mineralocorticoids; Rats; Time Factors | 1995 |
Adrenal steroids and cardiac fibrosis.
Topics: Aldosterone; Animals; Corticosterone; Desoxycorticosterone; Endomyocardial Fibrosis; Male; Mifepristone; Rats; Rats, Sprague-Dawley | 1995 |
Mineralocorticoids, hypertension, and cardiac fibrosis.
Topics: Aldosterone; Animals; Blood Pressure; Collagen; Desoxycorticosterone; Endomyocardial Fibrosis; Hydroxyproline; Hypertrophy, Left Ventricular; Male; Mifepristone; Rats; Rats, Sprague-Dawley | 1994 |
Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Collagen; Desoxycorticosterone; Endomyocardial Fibrosis; Fibronectins; Heart; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium, Dietary; Spironolactone; Tetrazoles | 1999 |
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Topics: Aldosterone; Animals; Blood Pressure; Cardiomegaly; Collagen; Desoxycorticosterone; Endomyocardial Fibrosis; Male; Myocardium; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Sodium, Dietary | 1992 |